Yatharth Hospital & Trauma Care Services Q1 FY26 results: net profit up 38.4% to ₹42.04 crore

How did Yatharth Hospital & Trauma Care Services perform in Q1 FY26?

Yatharth Hospital & Trauma Care Services reported consolidated revenue of ₹257.77 crore in Q1 FY26, up 21.7% from ₹211.78 crore in Q1 FY25 and 11.2% from ₹231.78 crore in Q4 FY25. EBITDA rose 20.2% year on year to ₹64.49 crore, while the EBITDA margin was 25.0%, compared with 25.3% in Q1 FY25 and 24.6% in Q4 FY25.

Profit after tax was ₹42.04 crore, compared with ₹30.38 crore in Q1 FY25 and ₹38.72 crore in Q4 FY25. Basic EPS was ₹4.36, up from ₹3.54 a year earlier and down from ₹4.37 in the previous quarter. The profit margin was 16.3%, compared with 14.3% in Q1 FY25 and 16.7% in Q4 FY25.

The board also approved unaudited standalone results for the quarter ended 30 June 2025. On that basis, revenue was ₹130.14 crore, up 9.4%, while profit after tax was ₹27.12 crore, compared with profit before tax of ₹23.15 crore.

What changed in Yatharth Hospital & Trauma Care Services' costs and profit?

Total expenses rose 20.8% from ₹172.48 crore in Q1 FY25 to ₹208.39 crore in Q1 FY26. Cost of materials increased by ₹6.71 crore to ₹53.51 crore, employee cost rose by ₹13.57 crore to ₹48.18 crore, depreciation increased by ₹3.48 crore to ₹14.92 crore, and other expenses rose by ₹14.89 crore to ₹91.60 crore.

Finance costs fell by ₹2.73 crore from ₹2.92 crore to ₹0.19 crore, while other income increased by ₹5.66 crore from ₹3.65 crore to ₹9.31 crore. There was no exceptional item. Tax expense increased by ₹4.08 crore from ₹12.57 crore to ₹16.65 crore.

As a result, EBITDA rose by ₹10.83 crore from ₹53.66 crore to ₹64.49 crore, profit before tax increased by ₹15.73 crore from ₹42.96 crore to ₹58.69 crore, and profit after tax rose by ₹11.66 crore from ₹30.38 crore to ₹42.04 crore. The filing did not attribute these movements to specific operational reasons.

How has Yatharth Hospital & Trauma Care Services done over the last 8 quarters?

Revenue increased in each of the last five quarters on a year-on-year basis and reached ₹257.77 crore in Q1 FY26, the highest point in the reported series. Profit after tax also rose year on year for five consecutive quarters and reached ₹42.04 crore, while the EBITDA margin moved up to 25.0% from 24.6% in Q4 FY25.

Over the same series, the EBITDA margin peaked at 27.8% in Q3 FY24 and bottomed at 24.6% in Q4 FY25. Revenue bottomed at ₹166.79 crore in Q3 FY24, while profit after tax was lowest at ₹27.60 crore in Q2 FY24. The latest quarter extended the upward revenue and profit trend, with margin recovering from the previous quarter.

What else did the company announce?

The board approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025 and filed an investor presentation for Q1 FY26. It also appointed MKP & Associates as secretarial auditor for five years, subject to shareholder approval, re-appointed Subodh Kumar & Co. as cost auditor for FY26, and appointed Saurav Upadhyay & Associates to scrutinise the AGM voting process.

The company disclosed the resignations of R Nagpal Associates as statutory auditor of the company and MAPPS & Company as statutory auditor of material subsidiary AKS Medical & Research Centre Private Limited with effect from 5 August 2025. Both said the proposed remuneration was not commensurate with the efforts required to conduct an audit under ICAI standards.

The board recommended MSKA & Associates, a BDO International member firm, as statutory auditor of the company and AKS Medical & Research Centre for five consecutive years, subject to shareholder approval. The same-day filings did not announce a dividend or a fund raise.

What did Yatharth Hospital & Trauma Care Services' management say?

In the 12 August 2025 earnings call, management maintained revenue growth guidance of about 30% for FY26 and said it expected the trajectory to continue beyond. It guided to an FY26 EBITDA margin of about 24%, with a ±1% range, against the Q4 FY25 base, including about 100 basis points of drag from the Delhi and Faridabad ramp-up, and guided to 8–10% blended ARPOB growth for FY26 and FY27.

Management said the company planned cumulative capex of ₹1,400–1,500 crore over three years to add about 1,200 beds, with annual maintenance capex of ₹20–25 crore. It expected the new Delhi and Faridabad hospitals to reach 30–35% occupancy within about 12 months and breakeven in about 15 months, based on the Greater Faridabad ramp-up template. The FY26 effective tax rate was expected at about 25–26%.

Management identified the new hospitals’ ramp-up, higher depreciation from expansion, an income-tax matter at AKS subsidiary that was not fully closed, and elevated receivables as risks. It said the two new hospitals could drag the group EBITDA margin by about 100 basis points against the Q4 FY25 base, while incremental depreciation was expected at ₹20–30 million per quarter. No analyst concerns were recorded in the provided call summary.

Yatharth Tyagi, Whole Time Director, said: “We are not chasing any particular targets in terms of number of beds. So, as and when good opportunities come, we will be scaling ourselves.” Group CEO Amit Kumar Singh made that statement. Management also said the company was not targeting international patients to contribute one-third of revenue.

How did Yatharth Hospital & Trauma Care Services shares react?

From the previous close of ₹651.00, the stock was up 5.2% by the close of the first session that could trade on the filing. By the next day’s close, it was up 7.7% from that pre-results close, and by the fifth session it was up 9.2%, measured cumulatively from the same base.

The Hospital industry’s median move was up 0.2% on the reaction day, down 0.5% by the next day and up 1.2% by the fifth session. Yatharth therefore exceeded the sector median by 5.0 percentage points on the reaction day, 8.2 percentage points by the next day and 8.0 percentage points by the fifth session.

Earlier reaction-day moves were 0.9% on 26 May 2025, -3.6% on 27 January 2025, -8.8% on 7 November 2024, -0.5% on 13 August 2024 and 0.5% on 23 May 2024. The Nifty Microcap 250 fell 0.4% on the reaction day, 1.4% by the next day and 2.4% by the fifth session.

How did other Hospital companies do?

Seventeen other Hospital companies filed for the quarter, with a median revenue growth of 14.9%. Of those companies, 14 grew more slowly than Yatharth Hospital & Trauma Care Services and three grew faster. Yatharth’s revenue growth was 21.7%.

Among 18 peers assessed for profit, 10 reported higher profit. The peer data is dated 6 November 2026.